Work

Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar Diseases

Year: 2023
Type: article
Abstract: Nanomedicine Drug-filled lipid nanocarriers are inhaled for deposition in the alveoli, spherical sacs that are the functional unit of the lung. In article number 2200106, Jacob S. Brenner and co-workers demonstrate that inhaled liposomes are stable in surfactant, avoid intra-alveolar macrophages, prolong drug half-life, and increase total drug delivered to the lung.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,610
OpenAlex ID: W4323866150
FWCI: 2.088
Cites:
Cited by: 13
Related to: 10